z-logo
open-access-imgOpen Access
Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure
Author(s) -
Nikola Kozhuharov,
Assen Goudev,
Dayana Flores,
Micha T. Maeder,
Joan Walter,
Samyut Shrestha,
Danielle Menosi Gualandro,
Múcio Tavares de Oliveira,
Zaid Sabti,
Christian Müller,
Markus Noveanu,
Thenral Socrates,
Ronny Ziller,
Antoni BayésGenís,
Alessandro Sionís,
Patrick Simon,
Eleni Michou,
Samuel Gujer,
Tommaso Gori,
Philip Wenzel,
Otmar Pfister,
David Conen,
Ioannis Kapos,
Richard Kobza,
Hans Rickli,
Tobias Breidthardt,
Thomas Münzel,
Paul Erné,
Christian Mueller,
for the GALACTIC Investigators
Publication year - 2019
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.18598
Subject(s) - medicine , heart failure , valsartan , clinical endpoint , vasodilation , randomized controlled trial , cardiology , hydralazine , intensive care , blood pressure , intensive care medicine
Short-term infusions of single vasodilators, usually given in a fixed dose, have not improved outcomes in patients with acute heart failure (AHF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom